Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-1-5
pubmed:abstractText
The oxidative injury to erythrocytes, red blood cell (RBC) rigidity and splenic hemolysis was assayed in 17 chronically hemodialyzed patients before and during recombinant erythropoietin (EPO) treatment. When a stable hematocrit between 30 and 35% had been established for at least 4 months, a statistically significant increase in RBC volume, hemoglobin concentration, hematocrit, reticulocyte count, and several RBC enzymes (2,3-diphosphoglycerate, glucose 6-phosphate dehydrogenase, pyruvate kinase, hexokinase) was noted. This indicated significant RBC rejuvenation under the influence of EPO. However, no significant improvement in the RBC oxidative sensitivity, RBC deformability, splenic RBC volume, slow mixing splenic RBC volume, and the intrasplenic RBC transit time could be disclosed. These data confirm the existence of an extra-erythrocytic factor in uremic plasma, which is partly responsible for a reduced RBC life span in hemodialysis patients despite EPO treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0028-2766
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
288-93
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8247195-Adult, pubmed-meshheading:8247195-Aged, pubmed-meshheading:8247195-Anemia, pubmed-meshheading:8247195-Erythrocyte Aging, pubmed-meshheading:8247195-Erythrocyte Deformability, pubmed-meshheading:8247195-Erythrocytes, pubmed-meshheading:8247195-Erythropoiesis, pubmed-meshheading:8247195-Erythropoietin, pubmed-meshheading:8247195-Female, pubmed-meshheading:8247195-Hematocrit, pubmed-meshheading:8247195-Hemolysis, pubmed-meshheading:8247195-Humans, pubmed-meshheading:8247195-Kidney Failure, Chronic, pubmed-meshheading:8247195-Male, pubmed-meshheading:8247195-Middle Aged, pubmed-meshheading:8247195-Oxidation-Reduction, pubmed-meshheading:8247195-Reactive Oxygen Species, pubmed-meshheading:8247195-Renal Dialysis, pubmed-meshheading:8247195-Sensitivity and Specificity, pubmed-meshheading:8247195-Spleen, pubmed-meshheading:8247195-Uremia
pubmed:year
1993
pubmed:articleTitle
Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
pubmed:affiliation
Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study